Biomedical Research: Genetics & Clinical Trials
Three-Week Summer Medicine Programs
Apply for this Program Now!
In this three week program, students will be introduced to the recent advances in genetics, genetic testing and personal genome sequencing, and will be presented with some of the decisions and ethical challenges an individual may face regarding the use of this technology. Students will also learn about some of the likely benefits of personal genetics, such as gaining the ability to act on one’s genetic risks, tailoring medicines and interventions, and becoming more active and engaged healthcare consumers.
Vince Coljee, Ph.D.
Vince Coljee is a scientist with a diverse background spanning biophysics and chemistry to various sub-disciplines of biology and therapeutics. Vincent worked in the biotech industry developing a new concept in biotherapeutics, human recombinant polyclonal antibodies, based on a very old idea, transferring immunity of those who are immune, to those who require that immunity but in a more concentrated, consistent and effective manner. Vincent pioneered this novel technology at Symphogen A/S in Denmark from 2000 to 2005 and then expanded on the technology at Excelimmune, Inc., a company he founded and was the Chief Scientific officer of from 2006 to December 2012. He also serves as an NIH grant reviewer. Vincent in collaboration with Mara Prentiss at Harvard University in 1999, helped develop a biophysics program studying DNA and DNA-protein interactions. In 2005, Vincent became a visiting scholar at Harvard University and a Harvard staff member in the Physics Department.
Join Our Mailing List
Register & Pay for a Program
Apply For a Three-Week Program